Pretreatment with ramiprilat induces cardioprotection against free radical injury in guinea-pig isolated heart: Involvement of bradykinin, protein kinase C and prostaglandins

Clinical and Experimental Pharmacology and Physiology

Volumn 27, Issue 4, 2000, Pages 257-262

  Jin, Zhu Qiu ^a   Chen, Xiu ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

Angiotensin converting enzyme inhibitor; Cardioprotection; Free radical; Prostaglandins; Ramiprilat

Indexed keywords

BRADYKININ; CALPHOSTIN C; FREE RADICAL; ICATIBANT; LACTATE DEHYDROGENASE; N(G) NITROARGININE METHYL ESTER; PROSTAGLANDIN; PROTEIN KINASE C; RAMIPRILAT; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; ENZYME ACTIVATION; GUINEA PIG; HEART FUNCTION; HEART INJURY; HEART PROTECTION; ISOLATED HEART; LIPID PEROXIDATION; MALE; NONHUMAN; PROSTAGLANDIN SYNTHESIS;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; BEPRIDIL; BRADYKININ; CARDIOVASCULAR AGENTS; CYCLOOXYGENASE INHIBITORS; DIASTOLE; FREE RADICALS; GUINEA PIGS; HEART; HEART RATE; INDOMETHACIN; L-LACTATE DEHYDROGENASE; MALE; MYOCARDIUM; NAPHTHALENES; NG-NITROARGININE METHYL ESTER; PICRATES; PROSTAGLANDINS; PROTEIN KINASE C; RAMIPRIL; RECEPTORS, BRADYKININ; THIOBARBITURIC ACID REACTIVE SUBSTANCES; VENTRICULAR FUNCTION, LEFT;

EID: 0034033173     PISSN: 03051870     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1681.2000.03233.x     Document Type: Article

References (22)

1. 1. Murry CE, Jennings RB, Reimer KA. Preconditioning with ischemia: A delay of lethal cell injury in ischemic myocardium. Circulation 1986; 74: 1124-36.
2. 2. Brew EC, Mitchell MB, Rehring TF et al. Role of bradykinin in cardiac functional protection after ischemia-reperfusion in rat heart. Am. J. Physiol. 1995; 269: H1370-8.
3. 2 receptors. Br. J. Pharmacol. 1994; 113: 1167-72.
4. 4. Jin ZQ, Chen X. Bradykinin mediates myocardial ischaemic preconditioning against free radical injury in isolated guinea pig heart. Clin. Exp. Pharmacol. Physiol. 1998; 25: 932-5.
5. 5. Michael A. Prostaglandins and the antiarrhythmic effect of preconditioning in the isolated rat heart. Mol. Cell. Biochem. 1992; 107: 648-52.
6. 6. Vegh A, Szekeres L, Parrat JR. Preconditioning of the ischaemic myocardium: Involvement of the L-arginine nitric oxide pathway. Br. J. Pharmacol. 1992; 107: 648-52.
7. 7. Li K, Chen X. Protective effects of captopril and enalapril on myocardial ischemia and reperfusion damage of rat. J. Mol. Cell. Cardiol. 1987; 19: 909-15.
8. 8. Pi XJ, Chen X. Captopril and ramiprilat protect against free radical injury in isolated working rat heart. J. Mol. Cell. Cardiol. 1989; 21: 1261-71.
9. 9. Ehring T, Baumgart D, Krajcar M et al. Attenuation of myocardial stunning by the ACE inhibitor ramiprilat through a signal cascade of bradykinin and prostaglandins but not nitric oxide. Circulation 1994; 90: 1368-85.
10. 10. Scholkens BA, Linz W, Koning W. Effect of the angiotensin converting enzyme inhibitor in isolated ischemic rat heart are abolished by a bradykinin antagonist. J. Hypertens. 1988; 6: S25-8.
11. 11. Yang X, Zhu Q, Fong J et al. Enalaprilat, an angiotensin-converting enzyme inhibitor, enhances functional preservation during long-term cardiac preservation, possible involvement of bradykinin and PKC. J. Mol. Cell. Cardiol. 1996; 28: 1445-52.
12. 2 receptor activation in human heart. J. Am. Coll. Cardiol. 1997; 29: 1599-606.
13. 2 receptor-NO pathway and protein synthesis. Br. J. Pharmacol. 1998; 125: 556-62.
14. 14. Okhawa H, Ohishi N, Yagi K. Assay of lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal. Biochem. 1978; 98: 351-8.
15. 15. Jin ZQ, Chen X. A simple reproducible model of free radical-injured isolated heart induced by 1,1-diphenyl-2-picryl-hydrazyl (DPPH). J. Pharmacol. Toxicol. Methods 1998; 39: 63-70.
16. 16. Baumgarten C, Linz W, Kunkel G et al. Ramiprilat increases bradykinin outflow from isolated hearts of rats. Br. J. Pharmacol. 1993; 108: 293-5.
17. 17. Nolly H, Carbinin L, Scicli G et al. A local kallikrein-kinin system is present in rat hearts. Hypertension 1994; 23: 919-23.
18. 18. Linz W, Wiemer G, Scholkens BA. ACE-inhibition induces NO formation in cultured bovine endothelial cells and protects isolated ischemic rat hearts. J. Mol. Cell. Cardiol. 1992; 24: 909-19.
19. 19. Woditsch I, Schror K. Prostacyclin rather than endogenous nitric oxide is a tissue protective factor in myocardial ischemia. Am. J. Physiol. 1992; 263: H1390-6.
20. 20. Imagawa J, Yellon DM, Baxter GF. Pharmacological evidence that inducible nitric oxide synthase is a mediator of delayed preconditioning. Br. J. Pharmacol. 1999; 126: 701-8.
21. 21. Bolli R, Bhatti ZA, Tang XL et al. Evidence that late preconditioning against myocardial stunning in conscious rabbits is triggered by the generation of nitric oxide. Circ. Res. 1997; 81: 42-52.
22. 22. Parrat JR. Protection of the heart by ischemic preconditioning: Mechanisms and possibilities for pharmacological exploitation. Trends Pharmacol. Sci. 1994; 15: 19-23.